Table 3.

Significantly deregulated miRNAs in bevacizumab‐responding patients and their correlation to proliferation at week 0.

miRNA	NeoAva		Nik‐Zainal et al.
	Correlationa	P‐valueb	Correlationa	P‐valueb
miR‐145‐5p	−0.53	1.65E−06	−0.21	1.13E‐01
miR‐99a‐5p	−0.48	4.33E‐05	−0.24	2.55E‐02
miR‐4324	−0.47	5.95E‐05	−0.15	1.00E+00
miR‐125b‐2‐3p	−0.47	6.63E‐05	−0.12	1.00E+00
miR‐100‐5p	−0.45	1.72E‐04	−0.23	3.99E‐02
miR‐125b‐5p	−0.45	2.06E‐04	−0.18	4.61E‐01
miR‐1181	0.46	1.32E‐04	0.21	8.74E‐02
miR‐4465	0.46	1.24E‐04	0.33	5.22E‐05

^aPearson correlation.

^bBH‐adjusted P‐values ≤ 0.05.